The U.S. Food and Drug Administration recently approved Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) for ...
PD-1 inhibitors belong to a class of medications known as immune checkpoint inhibitors, which have become an important part of many modern cancer treatment plans. PD-1 inhibitors work by helping the ...
ZME Science on MSN
Smart Drug Shrinks Tumors in Cancer Patients With No Options Left
In the world of cancer treatment, success stories are often hard to come by. But for patients battling advanced head and neck ...
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: ...
The US Food and Drug Administration (FDA) has approved the biologics license application for a subcutaneous formulation of lecanemab (Leqembi Iqlik) for weekly maintenance dosing to treat Alzheimer’s ...
Entera Bio’s osteoporosis candidate for postmenopausal women showed statistically significant improvements in bone density in ...
AstraZeneca’s Saphnelo (anifrolumab) has received a positive recommendation from the Committee for Medicinal Products for ...
Ascletis Announces Positive Interim Results from Its U.S. Phase Ib Trial with ASC30, a Potentially First-in-Class Subcutaneous Injection Small Molecule GLP-1R Agonist Ascletis Announces Positive ...
Halozyme Therapeutics has been busy. While fighting a patent dispute with Merck & Co. | Halozyme scoured very broadly for ...
Several sources are speculating that the potential buyer could be Eli Lilly, despite the breakdown of the pharma's ...
FDA approves Bravecto Quantum (fluralaner), the first annual injection against fleas and ticks in dogs, offering 12 months of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback